Literature DB >> 2644369

Immunization of cotton rats with the human respiratory syncytial virus F glycoprotein produced using a baculovirus vector.

M W Wathen1, R J Brideau, D R Thomsen.   

Abstract

The F glycoprotein of respiratory syncytial virus in insect cells was produced using a baculovirus expression vector to examine its potential as a subunit vaccine. Two different forms of the F glycoprotein were expressed: the intact F (F) glycoprotein and the truncated (Ft) glycoprotein, in which the COOH-terminal anchor region was deleted. The F glycoprotein remained cell associated, whereas the Ft glycoprotein was secreted into the media of infected cells. In contrast to the processing of the F0 precursor into its F1 and F2 subunits that was observed in mammalian cells, a second cleavage site within the F1 subunit was recognized by the insect cell proteases and resulted in the formation of two F1 subunits. The baculovirus-expressed Ft glycoprotein induced neutralizing antibodies in cotton rats and protected vaccinated animals from challenge with respiratory syncytial virus.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2644369     DOI: 10.1093/infdis/159.2.255

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

1.  Baculovirus expression of the respiratory syncytial virus fusion protein using Trichoplusia ni insect cells.

Authors:  M Parrington; S Cockle; P Wyde; R P Du; E Snell; W Y Yan; Q Wang; L Gisonni; S Sanhueza; M Ewasyshyn; M Klein
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

2.  Immunodominant T-cell epitope on the F protein of respiratory syncytial virus recognized by human lymphocytes.

Authors:  M E Levely; C A Bannow; C W Smith; J A Nicholas
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

3.  Baculovirus expression of the fusion protein gene of bovine respiratory syncytial virus and utility of the recombinant protein in a diagnostic enzyme immunoassay.

Authors:  M K Pastey; S K Samal
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948

4.  Expression and secretion of the bovine coronavirus hemagglutinin-esterase glycoprotein by insect cells infected with recombinant baculoviruses.

Authors:  M D Parker; D Yoo; L A Babiuk
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

5.  Immunological response of mice to the bovine respiratory syncytial virus fusion glycoprotein expressed in recombinant baculovirus infected insect cells.

Authors:  K Walravens; J P Matheise; I Knott; P Coppe; A Collard; C Didembourg; F Dessy; R Kettmann; J J Letesson
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

Review 6.  Hyperimmune globulins in prevention and treatment of respiratory syncytial virus infections.

Authors:  V G Hemming; G A Prince; J R Groothuis; G R Siber
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

7.  Expression of bovine herpesvirus 1 glycoprotein gIV by recombinant baculovirus and analysis of its immunogenic properties.

Authors:  S van Drunen Littel-van den Hurk; M D Parker; D R Fitzpatrick; T J Zamb; J V van den Hurk; M Campos; R Harland; L A Babiuk
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

8.  Bovine respiratory syncytial virus protects cotton rats against human respiratory syncytial virus infection.

Authors:  F M Piazza; S A Johnson; M E Darnell; D D Porter; V G Hemming; G A Prince
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

9.  Efficacy of mucosal polyanhydride nanovaccine against respiratory syncytial virus infection in the neonatal calf.

Authors:  Jodi L McGill; Sean M Kelly; Pankaj Kumar; Savannah Speckhart; Shannon L Haughney; Jamie Henningson; Balaji Narasimhan; Randy E Sacco
Journal:  Sci Rep       Date:  2018-02-14       Impact factor: 4.379

10.  Analysis of the S spike (peplomer) glycoprotein of bovine coronavirus synthesized in insect cells.

Authors:  D Yoo; M D Parker; L A Babiuk
Journal:  Virology       Date:  1990-11       Impact factor: 3.616

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.